Details for Patent: 5,166,207
✉ Email this page to a colleague
Summary for Patent: 5,166,207
Title: | Method for enhancing the systemic delivery of dextromethorphan for the treatment of neurological disorders |
Abstract: | A method for enhancing the systemic delivery of dextromethorphan for the treatment of a neurological disorder resulting in injury to nervous tissue, which comprises administering to a patient suffering from the disorder an amount of a cytochrome P450IID6 enzyme inhibitor, sufficient to block dextromethorphan metabolism, and an amount of dextromethorphan sufficient to treat the neurological disorder. Quinidine is particularly suitable for use in the method of the invention. |
Inventor(s): | Smith; Richard A. (La Jolla, CA) |
Assignee: | NeuroTherapeutics, Inc. (San Diego, CA) |
Application Number: | 07/717,424 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 5,166,207
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,166,207
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2114267 | ⤷ Sign Up | |||
Canada | 2712821 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |